WILMINGTON, Del. – Purdue Pharma LP’s deal to escape thousands of lawsuits over its role in the U.S. opioid crisis may be provide less than half the $10 billion that the drugmaker has promised, said three people familiar with details of the proposal. The settlement Purdue filed in bankruptcy court Sunday includes just $4.4 billion in…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.